Study of Pycnogenol (Horpagh Research) shows benefits for Menopausal women
A new clinical trial has found that natural supplement Pycnogenol, from Horpagh Research Ltd, minimizes climacteric symptoms of menopausal women. A randomized, placebo-controlled, double-blind, parallel-group clinical trial was conducted and participants were given either placebo capsules or 30 mg of Pycnogenol twice per day, over a period of 12 weeks.
According to the study, the total symptom improvement using the Kupperman index, which represents the most commonly utilized questionnaire in Japan, was statistically significant versus the placebo group. The study identified a number of further menopausal symptom improvements such as decreased heart palpitations which reached borderline statistical significance. See: "Effect of Low-dose French Maritime Pine Bark Extract on Climacteric Syndrome in 170 Perimenopausal Women: A Randomized, Double-blind, Placebo-controlled Trial." Takafumi Kohama et al. The Journal of Reproductive Medicine, vol 58 no 1 Feb 2013
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.